Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169065
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2005-09-10
Brief Title:
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
Sponsor:
Harvard Medical School HMS and HSDM
Organization:
Harvard Medical School HMS and HSDM
Study Overview
Official Title:
Clozapine vs Olanzapine An Effectiveness Study
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COES
Brief Summary:
This study will determine the effectiveness of clozapine versus olanzapine in treating people with schizophrenia that has not improved with treatment
Detailed Description:
This is a two-year open-label randomized trial of the comparative effectiveness of clozapine versus olanzapine in patients with treatment refractory schizophrenia The objective is to determine whether in a naturalistic setting olanzapine is a logical treatment choice before using the more toxic clozapine for some treatment refractory patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01MH049891 | NIH | None | httpsreporternihgovquickSearchR01MH049891 |